Clinical Trial: Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07130903) titled 'Amplitude-Modulated Radiofrequency Electromagnetic Fields (AM RF EMF) in Combination With Fruquintinib in Refractory Metastatic Colorectal Cancer' on Aug. 12.

Brief Summary: The goal of this clinical trial is to learn if adding amplitude-modulated radiofrequency electromagnetic fields (AM RF EMF) to Fruquintinib in metastatic colorectal cancer that has not responded to other standard treatment is:

* Effective in improving survival

* safe and tolerable

Study Start Date: Sept., 2025

Study Type: INTERVENTIONAL

Condition: Metastatic Colorectal Adenocarcinoma

Intervention: DRUG: Fruquintinib

Fruquintinib is a small molecule tyro...